Investor mix
6 investors on record; lead investors include Axil Capital, UTC Investment, Oita Venture Capital, Mitsubishi UFJ Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Private equity | 1 | 17% |
Developer of small molecule based therapeutics for the treatment of orphan and intractable diseases
6 investors on record; lead investors include Axil Capital, UTC Investment, Oita Venture Capital, Mitsubishi UFJ Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Private equity | 1 | 17% |